Australia seems poised to experience potentially transformative medication for obesity: Retatrutide. The dual molecule – acting on both GLP-1 and GIP receptors – shows significant results in international studies, indicating meaningful reductions in weight. While availability is Retatrutide Australia Weight Loss pending with Australian regulato